COR News

Cencora Appoints Mark Durcan as Chairman of Its Board of Directors

COR

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has appointed Lead Independent Director D. Mark Durcan as Chairman of the Board of Directors, effective October 1, 2025. Mr. Durcan will succeed Steven H. Collis, who has served as Cencora’s Chairman since 2016 and previously served as Cencora’s Chief Executive Officer from 2011 until 2024. As previously disclosed, Mr. Collis was elected to serve as Executive Chairman of the Board effective

CoreSite Completes Critical Upgrade of One Wilshire® Building Infrastructure

COR

LOS ANGELES--(BUSINESS WIRE)--The iconic One Wilshire® is one of the most interconnected buildings in the world, hosting more than 300 networks and home to a variety of data centers that serve businesses along the West Coast. Many consider it the most vital carrier hotel in the western U.S., with estimates of as much as a third of all trans-Pacific traffic passing through the building. As a legacy carrier hotel, it was in need of system upgrades to meet the needs of modern hybrid IT infrastruct

$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

COR

June 3, 2025
Read more →

Assessing Cencora: Insights From 6 Financial Analysts

COR

June 3, 2025
Read more →

Wells Fargo Upgrades Cencora to Overweight, Raises Price Target to $337

COR

June 3, 2025
Read more →

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today

COR

May 14, 2025
Read more →

Citigroup Maintains Buy on Cencora, Raises Price Target to $355

COR

May 8, 2025
Read more →

Baird Maintains Outperform on Cencora, Raises Price Target to $350

COR

May 8, 2025
Read more →

Cencora's Boosts Annual Forecast On Strong Demand For Weight Loss Drugs, Specialty Products Despite Mixed Q2 Earnings

COR

Cencora raised its 2025 earnings forecast after a strong Q2 driven by U.S. drug sales, though total revenue of $75.5 billion slightly missed expectations.

May 7, 2025
Read more →

Cencora Raises FY2025 Adj EPS Guidance from $15.30-$15.60 to $15.70-$15.95 vs $15.46 Est

COR

May 7, 2025
Read more →

Cencora Q2 Adj. EPS $4.42 Beats $4.11 Estimate, Sales $75.45B Miss $75.68B Estimate

COR

May 7, 2025
Read more →

UBS Maintains Buy on Cencora, Raises Price Target to $335

COR

April 29, 2025
Read more →

Here's How Much You Would Have Made Owning Cencora Stock In The Last 5 Years

COR

April 24, 2025
Read more →

Here's How Much You Would Have Made Owning Cencora Stock In The Last 10 Years

COR

April 17, 2025
Read more →

B of A Securities Maintains Neutral on Cencora, Raises Price Target to $285

COR

April 11, 2025
Read more →

These 5 S&P 500 Winners Held Strong In Q1 — Can The Rally Continue?

COR

A group of S&P 500 stocks have remained resilient as tariffs and earnings concerns cause the market to drop. Future gains may be limited.

April 7, 2025
Read more →

Here's How Much You Would Have Made Owning Cencora Stock In The Last 10 Years

COR

March 26, 2025
Read more →

Wells Fargo Maintains Equal-Weight on Cencora, Raises Price Target to $274

COR

March 14, 2025
Read more →

Cencora Expects 2025 Adjusted EPS Of $15.30-$15.60, Up From The Previous Range Of $15.25-$15.55 Compared To Consensus Of $16.82-8K

COR

March 10, 2025
Read more →

$100 Invested In Cencora 5 Years Ago Would Be Worth This Much Today

COR

February 14, 2025
Read more →

Cencora Acquires Retina Care Practice Network For $4.6 Billion, Boosts Dividend On Better Than Expected Q4 Earnings

COR

Cencora will potentially pay up to $500 million in aggregate contingent consideration in fiscal years 2027 and 2028.

November 6, 2024
Read more →

Cencora Forecasts 2025 Adjusted EPS Of $14.80-$15.10 Vs. $13.64 Est.

COR

November 6, 2024
Read more →

Cencora Has Introduced Its Full Fiscal Year 2025 Financial Guidance, Which Reflects Adjusted Operating Income Growth Of 5%-6.5% And Adjusted Diluted EPS Growth Of 8%-10%

COR

November 6, 2024
Read more →

Cencora Declared A Quarterly Dividend Of $0.55 Per Common Share, An 8% Increase In Its Quarterly Dividend Rate From $0.51 Per Common Share

COR

November 6, 2024
Read more →

Cencora Q4 2024 Adj EPS $3.34 Beats $3.22 Estimate, Sales $79.05B Beat $77.65B Estimate

COR

November 6, 2024
Read more →

Cencora Has Agreed To Acquire Retina Consultants Of America From Webster Equity Partners For Approximately $4.6B In Cash

COR

November 6, 2024
Read more →

Cencora Raises FY24 Adjusted EPS Guidance From $13.30 - $13.50 To $13.35 - $13.55, Est $13.44

COR

May 22, 2024
Read more →

Cencora Agrees To Repurchase Shares From Walgreens Boots Alliance Holdings In The Amount Of $400M In Private Transaction

COR

May 22, 2024
Read more →

Walgreens Boots Alliance Sells Shares Of Cencora For $400M Proceeds; Ownership Decrease From 13% To 12%

COR

May 22, 2024
Read more →

Here's How Much $1000 Invested In Cencora 5 Years Ago Would Be Worth Today

COR

May 16, 2024
Read more →